ASX CEO Sessions

The CEO Sessions

An opportunity for investors and advisers to hear directly from listed company CEOs on company strategy, prospects, and performance.

ASX and FNN are proud to present a program of forums for investors. Hear CEOs and senior representatives of listed companies present their investment story.
Join them afterwards for an informal meet and greet session, with lunch provided.

Register your attendance for an upcoming event

Upcoming Events in Sydney

21 February 2017

Ian Macoun
Noxopharm Limited (ASX:NOX)
Dr Graham Kelly, Managing Director & CEO

Noxopharm is an Australian drug development company with offices in Melbourne and Sydney. The Company has a primary focus on the development of drugs to address the problem of drug-resistance in cancer cells, the major hurdle facing improved survival prospects for cancer patients. NOX66 is the first pipeline product, with later generation drug candidates under development in an active R&D program.
Ian Macoun
ResApp Healh Limited (ASX:RAP)
Tony Keating, Managing Director & CEO

ResApp Health (ASX:RAP) is developing digital healthcare solutions to assist doctors and empower patients to diagnose and manage respiratory disease. The technology is based on machine learning algorithms that use sound alone to diagnose and measure the severity of respiratory conditions without the need for additional hardware. We are creating easy to use affordable, clinically-validated and regulatory-cleared diagnostic tools that only require a smartphone.
Ian Macoun
OneVue Limited (ASX:OVH)
Connie Mckeage, Managing Director

OneVue is a fintech company that partners to disrupt the superannuation value chain. OneVue delivers superannuation investors digital gateways between investors and their financial community. This includes the creation of a gateway between Fund Services (product creators) and Platform Services (distributors).
Ian Macoun
Nuheara Limited (ASX:NUH)
Justin Miller, CEO

Nuheara, in partnership with Curtin University in Western Australia developed an innovative augmented hearable (ear buds) that allows people to control their hearing experience. Nuheara's IQbuds promise to make it easier to hear in challenging environments; blocking out noise and enhancing speech.
Altech Chemicals Limited (ASX:ATC)
Iggy Tan, Managing Director

Altech Chemicals Limited (ASX:ATC) is aiming to become one of the world's leading producers of 99.99% (4N) high purity alumina (HPA) (Al2O3) through the construction and operation of a 4,000tpa HPA manufacturing plant at Tanjung Langsat, Johor, Malaysia.
NSL Consolidated Limited
Cedric Goode, Managing Director & CEO

NSL Consolidated (ASX:NSL) is a dual bulk commodity company, with iron ore production in India and thermal coal exploration in Australia.


Dexus at The CEO Sessions

Crowd at The CEO Sessions

Investor Audience at The CEO Sessions

Latest Videos

1 Sep 2010

Index Options

September ‘10 - Andy Semple explains the differences between stock and index options and the advantages of trading an option with broad based exposure.

30 Jul 2010

Long dated calls

August ‘10 - Andy Semple reminds us of all about the usefulness of a simple long dated call. Less risk than owning the underlying stock with built in protection at the strike price. Why not use a long dated call for your next buy and hold trade?

3 Jun 2010

Covered combos

June ‘10 - Andy Semple explains how to brings in two premiums writing out of the money puts and calls, potentially selling your stock for more or adding to your position for less than the current price.

5 May 2010

Bull Put Spreads

May ‘10 - Andy Semple explains how the Bull spread delivers a similar return to the protected buy write for a whole lot less capital.

30 Apr 2010

Time to gear into Shares

May ‘10 - 'AAA' Commercial Mortgages, MD, John Macalyk explains the pros & cons, citing Mike Tyson as inspiration.

1 Apr 2010

Margin Lending & Options

April ‘10 - Andy Semple explains why sensible gearing is a must and how to use it as a line of credit for options trading.

11 Feb 2010

Working capital alternatives

February ‘10 - 'AAA' Commercial Mortgages, MD, John Macalyk explains what’s available and how to qualify.

29 Jan 2010

Timing your option trades

January 2010 - Andy Semple talks trend trading basics and how to use these to time your option trades

10 Nov 2009

Direct property in SMSF

November 2009 - 'AAA' Commercial Mortgages, MD, John Macalyk explains the rules and advantages.

2 Nov 2009

Exchange Traded Options

November 09 – Andy Semple takes us through a Buy & Write on ANZ for Dec expiry with a 6.3% return if exercised for 52 days

2 Sep 2009

Construction Finance

September 2009 - 'AAA' Commercial Mortgages, MD, John Macalyk shows you where to get construction finance and the costs.

20 Jul 2009

Commercial property valuation

July 2009 - MD, John Macalyk, 'AAA' Commercial Mortgages takes us through the valuation process using an example of a commercial property in Randwick, NSW as a case in point.

17 Jun 2009

Commercial property opportunities - June 09

MD, John Macalyk, 'AAA' Commercial Mortgages shares his considerable experience, looks at several properties and explains why he favours variable over fixed rate funding.